NewslettersExtracellular Matrix News Verteporfin Ameliorates Fibrotic Aspects of Dupuytren’s Disease Nodular Fibroblasts Irrespective the Activation State of the Cells By Danielle Corrigan - August 18, 2022 0 Researchers investigated whether verteporfin was able to inhibit the activation and subsequent differentiation of Dupuytren’s disease nodular fibroblasts into myofibroblasts. [Scientific Reports] Full Article